TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
We showed that GBE treatment induced an increase of phosphorylated IGF1R (Tyr1135/Tyr1136), Akt (Ser473), TSC2 (Ser939), mTOR (Ser2448), PTEN (Ser380) and GSK3β (Ser9).
|
31790465 |
2019 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Previously reported "in vitro" experiments with mouse 3T3 fibroblasts demonstrated oncogenic potential of PIK3CB p.D1067V and mTOR p.L2209V mutants; whereas, PolyPhen-2 software analysis predicted TSC2 p.K347R mutation to likely have a damaging impact on tuberin function.
|
28777148 |
2019 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Homozygous knock-in mice that express a phosphorylation-silencing mutation in TSC2 (TSC2(S1365A)) develop worse heart disease and have higher mortality after sustained pressure overload of the heart, owing to mTORC1 hyperactivity that cannot be rescued by PKG1 stimulation.
|
30700906 |
2019 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings.
|
29926239 |
2018 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Rare familial TSC2 gene mutation associated with atypical phenotype presentation of Tuberous Sclerosis Complex.
|
28127866 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Employing a transient transfection-based approach to rescue TSC2 function in muscles of the iTSC2KO mice, we demonstrated that these phosphorylation sites are required for the role that TSC2 plays in the EC-induced activation of mTOR signaling.
|
28289099 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Phenotypic and genotypic characterization of Chinese children diagnosed with tuberous sclerosis complex.
|
27859028 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.
|
28065512 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
As a model for mTORC1 activation we used gene suppression of its physiological inhibitor TSC2 (TSC2sh).
|
28969371 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.
|
28968464 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability.
|
28149746 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Combination of Multiple Ligation-Dependent Probe Amplification and Illumina MiSeq Amplicon Sequencing for TSC1/TSC2 Gene Analyses in Patients with Tuberous Sclerosis Complex.
|
28087349 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel.
|
29056246 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
|
29196670 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Phenotypic and genotypic characterization of Chinese children diagnosed with tuberous sclerosis complex.
|
27859028 |
2017 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.
|
26703369 |
2016 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency.
|
27078846 |
2016 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Comparison of Color Fundus Photography, Infrared Fundus Photography, and Optical Coherence Tomography in Detecting Retinal Hamartoma in Patients with Tuberous Sclerosis Complex.
|
27174333 |
2016 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Has mother has a tuberous sclerosis 2 (TSC 2) gene abnormality and a diagnosis of tuberous sclerosis.
|
27174083 |
2016 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Similar changes are observed in Raf kinases following TGHQ-mediated transformation of primary renal epithelial cells derived from Tsc-2(EK/+) rats (QTRRE cells), cells that are also null for tuberin.
|
26333016 |
2016 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.
|
25432535 |
2015 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations.
|
25927202 |
2015 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
|
26104489 |
2015 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.
|
25782670 |
2015 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
TSC1 R509X Mutation in a Chinese Family with Tuberous Sclerosis Complex.
|
25900779 |
2015 |